Article
Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder.
Journal of pineal research - 1 May 2010
Gałecki Piotr, Szemraj Janusz, Bartosz Grzegorz, Bieńkiewicz Małgorzata, Gałecka Elzbieta, Florkowski Antoni, Lewiński Andrzej, Karbownik-Lewińska Małgorzata
Abstract excerpt
Depressive disorder (DD) is characterised by disturbances in blood melatonin concentration. It is well known that melatonin is involved in the control of circadian rhythms, sleep included. The use of melatonin and its analogues has been found to be effective in depression therapy. Melatonin synthesis is a multistage process, where the last stage is catalysed by acetylserotonin methyltransferase (ASMT), the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
